Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.
Woodruff PG, Chatila W, Connett JE, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Marchetti N, Rogers TJ, Scanlon PD, Sin DD, Voelker H, Wendt C, Albert RK; COPD Clinical Research Network.
Woodruff PG, et al.
Eur Respir J. 2014 Jan;43(1):295-8. doi: 10.1183/09031936.00140613. Epub 2013 Oct 17.
Eur Respir J. 2014.
PMID: 24136332
Free PMC article.
Clinical Trial.
No abstract available.